Match each of the following clinical investigation objectives with the epidemiological study design that is optimally suited to address it.
- Determining the current prevalence of unrecognized chronic kidney disease within a specific metropolitan area during a single calendar year.Cross-sectional study
- Identifying potential past environmental exposures associated with the development of an exceedingly rare, newly identified neurodegenerative disorder.Case-control study
- Measuring the 15-year incidence of hepatocellular carcinoma by enrolling healthy volunteers, classifying them by baseline alcohol consumption, and tracking their outcomes.Prospective cohort study
- Evaluating whether a novel biologic agent is clinically superior to standard-of-care therapy for maintaining remission in patients with moderate-to-severe Crohn disease.Randomized controlled trial
Cevap
The correct pairings are: prevalence determination with cross-sectional study, rare disease etiology with case-control study, long-term incidence measurement with prospective cohort study, and therapeutic efficacy evaluation with randomized controlled trial.
Each study design is optimally matched to its distinct methodological strength. Cross-sectional studies provide prevalence data. Case-control studies are highly efficient for rare diseases because they secure a sufficient number of cases upfront. Prospective cohort studies are best for establishing incidence and temporal relationships between exposure and disease. Randomized controlled trials minimize confounding to definitively assess treatment efficacy.
Adım Adım Çözüm
Anahtar Kavram
Selection of epidemiological study designs based on research objectives, disease rarity, and temporal relationships.
Tahmini Süre:1m 30s